NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Australia
Incannex Healthcare Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.
Incannex Healthcare creates investigational medicines combining multiple active agents to treat serious long-term illnesses. Its primary focus is IHL-42X for obstructive sleep apnea, alongside PSX-001 pairing synthetic psilocybin with therapy for generalized anxiety disorder, and IHL-675A merging cannabidiol with hydroxychloroquine for inflammatory disorders.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Incannex Healthcare Inc stock.
Not valued: We cannot value this company yet.
All 84 Drug Manufacturers - Specialty & Generic stocks
35 more in this industry show a wider margin of safety.
We do not publish a verdict on IXHL yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.